Meet our CEO at PharmSci360 in Florida!

Join our session RxE2 CEO, Gerald Finken, will be taking part in a panel titled: “The Integration of Clinical Trials and Clinical Care: A Revolution in the Participant and Sponsor Experience or an Implementation Nightmare? Or Both?” When & Where Monday, October 23, 2023 | 7:00 AM – 9:00 AM ET | Location:308 AB West Meet…

Meet RxE2 at GCSG2023!

Meet us at GCSG 2023!

RxE2 is disrupting the clinical supply chain to improve quality and eliminate waste – Meet us at #GCSG2023! Current supply chain logistics provide ample opportunity for risk and waste. What if we eliminate that? Led by Gerald E. Finken, the inventor of On-Demand Packaging & Labeling, RxE2 is de-risking the process by eliminating unnecessary steps for truly patient centric…

Meet RxE2 in San Francisco!

Our team will be in San Francisco during the J.P. Morgan Healthcare Conference and is ready to meet with investors and industry leaders. We will also be taking part in the First Analysis Healthcare Technology Conference – 2023. Reach out to  Gerald Finken or to David Stark to schedule a meeting!

RxE2 announces investment from Badlands Capital

Fargo, ND, October 2022 RxE2 is happy to announce a recent investment from Badlands Capital. “I am so pleased to be working with Badlands Capital, especially since RxE2 is headquartered in Fargo, ND. The Badlands team truly understand what clinical trial innovation looks like and the magnitude of what RxE2 is and will accomplish, as we solve the recruitment, diversity,…

RxE2 Joins PQA

RxE2 Joins Pharmacy Quality Alliance

RxE2 is proud to be a member of the PQA, a non-profit organization with 250 diverse members across healthcare. Now more than ever we need to bring the practice of pharmacy into clinical trials. Incorporating PQA programs like Pharmacist Provided Care and Medication Use Quality will change the future outcomes for any clinical trial program…